- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02481908
STI Combined to Valsalva Maneuver for the Diagnosis of Left Ventricular Dysfunction in COPD Exacerbations (STICOPD)
September 10, 2020 updated by: Pr. Semir Nouira, University of Monastir
a New and Non Invasive Method to Calculate STI ( Systolic Time Intervals) Combined to Valsalva Maneuver in Patient With Acute Exacerbation of COPD
The aim of this investigation was to assess the value of Systolic Time Intervals (STIs) as a method of detecting Left Ventricular Dysfunction (LVD) in patients admitted to the emergency department for cute exacerbations of chronic obstructive pulmonary disease (AECOPD) and whether STIs measured under Valsalva manoeuver (VM) could improve the distinction between patients with LVD and those without LVD.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
We included patients admitted to the ED for AECOPD.
Measurement of STIs included electromechanical activation time (EMAT), left ventricular ejection time and EMAT/LVET ratio.
These were performed at baseline and during the first strain phase of the VM using a computerized phono and electrocardiographic method.
The diagnosis of LVD was determined on the basis of clinical examination, echocardiography and brain natriuretic peptide.
The values of STIs were compared between patients with and without LVD ; their diagnostic performance was assessed using the area under receiver operating characteristic curve (AUC of ROC).
Study Type
Observational
Enrollment (Actual)
189
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Monastir, Tunisia, 5000
- CHU Fattouma Bourguiba
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
It is a prospective study of patients visiting the emergency department of the hospital Fattouma Bourguiba Monastir with decompensated chronic obstructive pulmonary disease COPD
Description
Inclusion Criteria:
- Oxygen Saturation (SPO2) <90%,
- Respiratory Rate >25c/min,
- PaCO2 > 6 kPa et pH< 7.35.
Exclusion Criteria:
- Neurological distress and hemodynamic instability
- Confusion, agitation
- pneumothorax
- Non cooperative patients
- Refusal of consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
diagnosis of left ventricular dysfunction
Time Frame: during the first day admission in emergency department
|
Systolic time intervals measured at baseline and under Valsalva maneuver
|
during the first day admission in emergency department
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: SEMIR NOUIRA, Pr, Fattouma Bourguiba University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2012
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
May 7, 2015
First Submitted That Met QC Criteria
June 22, 2015
First Posted (Estimate)
June 25, 2015
Study Record Updates
Last Update Posted (Actual)
September 14, 2020
Last Update Submitted That Met QC Criteria
September 10, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STI in COPD
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Chronic Bronchitis With Acute Exacerbation
-
Parc de Salut MarCompletedObstructive Chronic Bronchitis With Acute ExacerbationSpain
-
Northumbria Healthcare NHS Foundation TrustNewcastle-upon-Tyne Hospitals NHS Trust; National Institute for Health Research... and other collaboratorsCompletedPulmonary Disease, Chronic Obstructive | Emphysema | Chronic Bronchitis | Pulmonary Disease, Obstructive | Chronic Bronchitis With Airways Obstruction | Chronic Bronchitis With Acute ExacerbationUnited Kingdom
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.UnknownAcute Exacerbation of Chronic BronchitisChina
-
PharmaKingCompletedAcute Exacerbation of Chronic BronchitisKorea, Republic of
-
AbbottCompletedAcute Bacterial Exacerbation of Chronic Bronchitis (ABECB).United States, Canada, Puerto Rico
-
Neutec Ar-Ge San ve Tic A.ŞUnknownAcute Exacerbation of Chronic Bronchitis | Community-Acquired PneumoniaeTurkey
-
SanofiCompletedCommunity Acquired Pneumonia (CAP) | Acute Exacerbation of Chronic Bronchitis (AECB)
-
BayerCompletedChronic Bronchitis | Disease ExacerbationChina
-
Ruijin HospitalNot yet recruitingCOPD Exacerbation | Bronchiectasis With Acute ExacerbationChina
-
University of MilanCompleted
Clinical Trials on STI measurements at baseline and under Valsalva maneuver
-
University of MonastirCompletedAcute Heart FailureTunisia
-
Medical University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD); Ralph...CompletedVitamin D Deficiency | Prostate Cancer | Stress ReactionUnited States